Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. (Q30376254)

21 June 2017

title

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. (English)

1 reference

21 June 2017

1 reference

16

Emanuele Montomoli

1 reference

21 June 2017

9

Rino Rappuoli

1 reference

21 June 2017

14

Hanna Nohynek

1 reference

21 June 2017

Syed Sohail Ahmed

1

1 reference

21 June 2017

Wayne Volkmuth

2

1 reference

21 June 2017

José Duca

3

1 reference

21 June 2017

Lorenzo Corti

4

1 reference

21 June 2017

Michele Pallaoro

5

1 reference

21 June 2017

Alfredo Pezzicoli

6

1 reference

21 June 2017

Anette Karle

7

1 reference

21 June 2017

Fabio Rigat

8

1 reference

21 June 2017

Vas Narasimhan

10

1 reference

21 June 2017

Ilkka Julkunen

11

1 reference

21 June 2017

Arja Vuorela

12

1 reference

21 June 2017

Outi Vaarala

13

1 reference

21 June 2017

Franco Laghi Pasini

15

1 reference

21 June 2017

Claudia Trombetta

17

1 reference

21 June 2017

Christopher M Adams

18

1 reference

21 June 2017

Jonathan Rothbard

19

1 reference

21 June 2017

Lawrence Steinman

20

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 July 2015

1 reference

Science Translational Medicine

21 June 2017

published in

1 reference

21 June 2017

volume

7

1 reference

21 June 2017

issue

294

1 reference

21 June 2017

page(s)

294ra105

1 reference

The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

MF59 adjuvanted seasonal and pandemic influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Is the adjuvant solely to blame?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Incidence of Narcolepsy in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Post-H1N1 narcolepsy-cataplexy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

HLA dosage effect in narcolepsy with cataplexy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Hypocretin (orexin) deficiency in human narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Variants of the orexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Factors associated with a delay in the diagnosis of narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

21 January 2018

Narcolepsy in childhood

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Comparative analysis of six European influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Identification of a highly conserved and surface exposed B-cell epitope on the nucleoprotein of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Tapping the immunological repertoire to produce antibodies of predetermined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Antibodies That React with Predetermined Sites on Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

B Cell in Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Children and encephalitis lethargica: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Estimates of the true number of cases of pandemic (H1N1) 2009, Beijing, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Unravelling the pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Endogenously expressed matrix protein M1 and nucleoprotein of influenza A are efficiently presented by class I and class II major histocompatibility complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Cross-presentation: underlying mechanisms and role in immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Assessing the safety of adjuvanted vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Conserved and host-specific features of influenza virion architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Identification of common molecular subsequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Searching protein sequence libraries: Comparison of the sensitivity and selectivity of the Smith-Waterman and FASTA algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

The influenza virus resource at the National Center for Biotechnology Information

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

Influenza research database: an integrated bioinformatics resource for influenza research and surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB2354

10.1126/SCITRANSLMED.AAB2354

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference